Edgar B. Cale bought PASG once, on Mar 3, 2020

Edgar B. "Chip" Cale was the General Counsel and Corporate Secretary of Passage Bio, Inc., a genetic medicines company focused on therapies for rare, monogenic central nervous system disorders.( He joined Passage Bio in September 2019 as General Counsel and was appointed Corporate Secretary in December 2019, later serving as interim chief executive officer during a leadership transition.( As a senior legal executive, he brought more than 30 years of global experience in corporate law, mergers and acquisitions, collaborations, intellectual property, securities law, and legal management, working with both large multinational organizations and startup companies.(

Before Passage Bio, Cale spent over two decades at GlaxoSmithKline, most recently as Senior Vice President of Legal Corporate Functions, where he oversaw legal support for global business development and corporate functions and previously served as General Counsel of GSK’s Vaccine division.( He held a BA in Biology from the University of Pennsylvania and a JD from the University of California, Berkeley, grounding his executive legal career in both scientific and legal training.( His role at Passage Bio encompassed leading the company’s legal strategy, corporate governance, and securities matters as a public biotech company, with compensation reflective of a top-tier executive, earning $881,920 in total compensation in one reported year as General Counsel and Corporate Secretary.(

Written by Perplexity from public sources.